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Abstract
Background: The H1N1 influenza pandemic had garnered a large amount of attention. Currently, the most
effective preventive measure available is the H1N1 vaccine. We aimed to assess the willingness of our study
participants to receive the H1N1 vaccination prior to the annual Hajj season. If any participant declined, we
investigated the reasons for vaccine rejection.
Findings: We conducted a prospective cohort study of National Guard employees during the 1430 (2009) Hajj
season. A survey was used as the primary method for data collection. Participants were vaccinated one to two
weeks prior to their trip to Mona, and any side effects reported at the time of injection and three weeks post
vaccination were recorded.
There were 100 male and 26 female participants in the study. In total, 66.7% (n = 84) of the participants were
health care workers (HCWs) and 33.3% (n = 42) were non-health care workers (non-HCWs). Less than half of the
respondents (46.8%, n = 59) accepted the vaccination. The vaccination acceptance rate was higher among non-
HCWs, at a rate of 71.4% (n = 30); HCWs only accepted at a rate of 34.5% (n = 29) (OR 1.103, 95% CI [0.488-2.496]).
The most common reason for vaccine refusal was the impression that the disease was not fatal (25.4%, n = 32).
Finally, all participants reported pain at the injection site and 18.3% (n = 11) reported swelling. All other side
effects were reported in less than 15% of the participants.
Conclusions: Despite fears of the new H1N1 vaccine, there was a reasonable rate of vaccine acceptance among
our study participants. Early health education may increase the rate of acceptance of the H1N1 vaccine.
Furthermore, additional research is needed on long-term adverse effects of the H1N1 vaccine.
Findings
The Hajj is an annual Muslim pilgrimage that begins on
the first day of Dul-Hajja (12
th lunar month) and con-
tinues for 13 days. The Hajj occurs at the holy city of
Mecca in the Kingdom of Saudi Arabia (KSA). The two-
to three-million people who gather in the small,
confined holy sites of the city come from multiethnic
Muslim communities around the world [1-3].
The Saudi National Guard is a military and security
force that includes several sub-administrations, of which
one is the National Guard Health Affairs. This group is
charged with providing health care services to National
Guard personnel and their dependents. The group also
offers medical services as necessary during the Hajj and
other similar situations involving large groups of people.
Influenza pandemics are significant health threats that
have occurred periodically over the past 300 years [4].
T h em o s ts e v e r ei n f l u e n z ap a n d e m i c ,o c c u r r i n gf r o m
1918 to 1919, killed approximately 30 to 50 million peo-
ple worldwide. The emergence of the H5N1 avian influ-
enza in 1997 promoted the recognition of the threat of
another severe pandemic as a significant possibility, and
such a pandemic would certainly be a threat at large
gatherings such as the annual Hajj [5]. In response to
this emerging threat, large-scale mitigation strategies
have been developed. One cornerstone of these efforts is
mass vaccination [6]. The current H1N1 pandemic,
which was first recognized and defined in Mexico City
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Before the current Hajj season of 2009, the WHO
declared there have been more than 300,000 laboratory
confirmed cases of pandemic influenza H1N1 and 3,917
deaths in 191 countries [7].
In the current study, we assessed the acceptance of
the H1N1 vaccination. We also examined possible bar-
riers to vaccination within this high-risk cohort of
employees, including both HCWs and non-HCWs, who
worked at one of the largest human gatherings in the
world.
Materials and methods
Setting
We conducted our study in Jeddah, the second-largest
city in the KSA, where the National Guard medical and
security teams were assigned to serve during the past
Hajj season. Participants were recruited from the King
Khalid National Guard Hospital, where the administra-
tion had assigned 150 HCWs and 350 non-HCWs for
both health care and security services. This total num-
ber of employees was considered to be the baseline
population for our study sample recruitment.
Study design
The study was designed as a prospective cohort study.
Participants were interviewed by the primary investiga-
tor after verbal consent was obtained. The first section
of the interview included the collection of the following
information: demographic characteristics, interest in
vaccination, and reasons for refusing vaccination (if
applicable). The second section of the interview focused
on any experienced side effects (if applicable). The inter-
view was conducted with all the employees staffed at the
vaccination clinic two weeks prior to the beginning of
the Hajj. After consenting to participate in the study,
respondents were assessed for baseline measures, as well
as signs and symptoms of the flu. After the assessment,
willing participants were vaccinated. The cohort was fol-
lowed during the Hajj for seven days and assessed one
week after the end of the Hajj, a time when all employ-
ees had returned to their jobs in Jeddah City.
Sample estimation
The sample size was estimated based on results from a
previous study showing that 5% of participants declined
the H1N1 vaccine [8]. Therefore, to determine an
appropriate sample size for this study, we assumed that
10% of our population would refuse the vaccine. With a
5% margin for error and a power of 80%, these assump-
tions resulted in a necessary sample size of 199 partici-
pants. However, due to several logistic constraints,
including delays in shipping by the manufacturing
companies, only 126 participants (64% of the target
sample size) were recruited.
Selection of participants
All National Guard HCWs and non-HCWs assigned to
serve during the Hajj season in the National Guard
campus clinics were expected to visit the staff clinic to
complete paperwork. Participants were recruited for the
study two weeks prior to their travel to Mecca, and
those who gave consent were interviewed. Inclusion cri-
teria included being a National Guard employee and
being assigned to serve during the 2009 Hajj season.
Those with positive results on an H1N1 PCR-based
assay during the current influenza season were excluded
from the study.
Instrument
The questionnaire was written in English, translated
into Arabic, and back-translated into English. It was
reviewed by an experienced bilingual medical research
staff member for content validity. Both forms were
reviewed and approved by the Institutional Review
Board of the King Abdullah International Medical
Research Center (IRB of KAIMRC). The questionnaire
contained 30 questions that focused on identifying
information and socio-demographic characteristics.
Those who accepted the vaccine were followed-up and
questioned about immediate side effects. Those who
refused the vaccine were questioned about their reasons
for declining and about the most effective preventive
measures they would apply in place of vaccination.
Interviews and data collection
All interviews were conducted during the employees’ visit
to the staff clinic, which was two weeks prior to arriving
at Mecca. The follow-up lasted for a one-week period
that followed the employees’ work during the Hajj.
A final follow-up visit for each participant occurred no
less than ten days after the end of the Hajj. All questions
were administered by a single interviewer to reduce pos-
sible bias. Each interview lasted for ten minutes, and the
interviewer reviewed the questions for completeness after
the end of each interview.
Vaccine
The Pandemrix H1N1 vaccine was administered during
the study. Each 0.5-ml vaccine was injected intramuscu-
larly into the upper arm. This medication is a split inac-
tivated influenza virus vaccine containing antigen
equivalent to the A/California/7/2009(H1N1)v-like strain
(X-179A). Each 0.5-ml dose contained 3.75 μgo fe g g -
propagated hemagglutinin-containing immunologic
adjuvant [9].
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Data entry was performed using Microsoft Excel. After
entry, the data were transferred to SPSS version 17 soft-
ware for detailed descriptive analysis. The means and
standard deviations of age were calculated.
Results
Demographic characteristics of study participants
A total of 126 of 500 assigned employees were recruited
for the study (25.2%). Of the total study participants,
100 (79.4%) were male and 26 (20.6%) female, with a
mean age of 38.7 and standard deviation of 9.8 years.
The majority of participants (n = 67, 53.2%) refused the
H1N1 vaccination and preferred using other protective
measures. The participants who were non-HCWs had a
vaccine acceptance rate of 71.4%, whereas HCWs had a
vaccine acceptance rate of 34.5% (OR of 1.103, 95% CI
[0.488-2.496]).
Vaccine acceptance and preventive measures for disease
transmission
Table 1 shows that 27 (21.4%) of the participants who
refused vaccination cited safety as the major reason for
refusal. There were 29 (23.0%) participants who cited the
presence of toxic preservatives in the vaccine (adjuvant
and mercury) as their major reason for refusal. Addition-
ally, 25 (19.9%) participants cited the difference of the
vaccine from the one provided to western communities,
which does not contain an adjuvant or mercury. There
were 26 (20.6%) participants who reported having
received confusing information from the media and the
government; they blamed the media for misleading
the public about the spread of the disease, its fatality, and
the long- and short-term toxic effects of the vaccine. In
addition, 32 (25.4%) participants claimed that the swine
flu was not a fatal disease and that becoming infected
was preferable to receiving the vaccination. Furthermore,
31 (24.6%) participants thought that their environment
was not optimal for a swine flu outbreak. Two partici-
pants stated that they would have accepted the vaccine
had it been available as a nasal spray. Additionally, four
HCWs claimed that they had already been exposed to
infected patients during their daily clinical practice and
had become carriers; therefore, they believed that they
probably already had an acquired immunity. Other parti-
cipants preferred applying alternative protective mea-
sures in lieu of accepting the vaccination. Of these
participants, 19 (15.8%) preferred to eat honey, and
25 (19.8%) preferred to eat citrus fruits as immunity
strengtheners. All participants reported frequent hand
washing, and 63 (50.0%) also reported wearing a mask as
an additional protective measure.
Adverse vaccine events
The adverse events listed in Table 2 show that 100% of
participants reported feeling localized pain and soreness,
and 11 (18.3%) reported minor local swelling at the site
of injection. Headache and body aches were reported in
Table 1 Sociodemographic characteristics of National Guard employees assigned to serve during the 2009 Hajj season
and reasons for refusing the H1N1 vaccination
Reasons for refusal Refusing
n (%)
Sex
n (%)
Employee status
n (%)
Male
n = 100
Female
n=2 6
HCWs
n=4 2
Non-HCWs
n=8 4
No adequate safety studies 27
(21.4%)
20
(15.9%)
7
(5.5%)
2
(1.6%)
25
(19.8%)
Contains toxic preservatives 29
(23.0%)
21
(17.0%)
8
(06%)
3
(2.4%)
26
(20.6%)
Different from western vaccine 25
(19.9%)
18
(14.4%)
7
(5.5%)
1
(0.9%)
24
(19.0%)
Misleading media information 26
(20.6%)
23
(18.3%)
3
(2.3%)
12
(09.5%)
14
(11.1%)
Swine flu not a fatal disease 32
(25.4%)
25
(19.9%)
7
(5.5%)
7
(5.5%)
25
(19.9%)
This is not an environment for H1N1 31
(24.6%)
25
(19.9%)
6
(4.7%)
9
(7.1%)
22
(17.5%)
Frequent hand washing 126
(100%)
100
(79.4%)
26
(20.6%)
36
(28.6%)
90
(71.4%)
Wearing a mask 63
(50.0%)
48
(38.1%)
15
(11.9%)
13
(10.3%)
50
(39.7%)
Eating honey 19
(15.8%)
14
(11.2%)
05
(04.6%)
7
(05.5%)
12
(10.3%)
Eating citrus 25
(19.8%)
21
(16.7%)
4
(03.2%)
6
(04.7%)
19
(15.1%)
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pants reported feeling fatigue and malaise. All other
adverse events occurred in less than 15% of the partici-
pants, Table 1.
Follow-up period
At the end of the follow-up period, which was approxi-
mately three weeks after receiving the vaccination, all
participants were interviewed about whether they would
be willing to receive the same vaccination if they were
approached the following year. Overall, 94.9% of those
vaccinated answered positively, whereas only 17.9% of
those who refused vaccination answered positively. The
main explanation from the latter group was that they
had not experienced any of the adverse effects that were
experienced by their colleagues following the vaccina-
tion. The remaining 82.1% of those who refused vacci-
nation stated that they were still worried about its long-
term adverse effects. The distribution of responses is
illustrated in Figure 1.
Discussion
In 2009, the large gathering of the annual pilgrimage
(known as the Hajj) occurred concomitantly with the
swine flu pandemic and the global panic surrounding the
possibility of a rapid outbreak. For these reasons, we
were interested in studying high-risk participants who
were assigned to provide services during the pilgrimage.
This allowed us to gather information about their atti-
tudes toward the H1N1 vaccine. We were also interested
in identifying and assessing the short-term adverse effects
of the newly manufactured vaccine [10]. Regarding the
current pandemic, the WHO had recommended that all
countries give high priority to immunizing their HCWs
to protect the essential health infrastructure. Despite
these recommendations, the acceptance of voluntary vac-
cination was unexpectedly low [11].
This study explored reasons for swine flu vaccination
refusal during a time of global public concern and
anticipation of a global outbreak. In our cohort of Saudi
National Guard employees assigned to work during the
Hajj, 46.8% of participants accepted the vaccination. We
Table 2 Common adverse effects of H1N1 vaccination among National Guard employees assigned to serve during the
2009 Hajj season
Adverse Effects Present Sex
Total Number (%) Male Number (%) Female Number (%)
Pain at injection site 59
(100%)
46
(78.1%)
13
(21.9%)
Swelling at injection site 11
(18.3%)
09
(15.3%)
2
(3.0%)
Headache 8
(13.4%)
06
(10.2%)
2
(3.2%)
Body ache 8
(13.4%)
07
(11.9%)
1
(1.5%)
Fatigue 20
(33.3%)
17
(28.8%)
3
(4.5%)
Fever 3
(5.1%)
3
(5.1%)
0
Vomiting 2
(3.4%)
2
(3.4%)
0
Flu-like illness 3
(5.1%)
3
(5.1%)
0
Dizziness 1
(1.7%)
1
(1.7%)
0
Numbness 1
(1.7%)
1
(1.7%)
0
0
10 
20 
30 
40 
50 
60 
70 
Yes 94.9% No 5.1% Yes 17.9% No 82.1% 
Accepted
vaccine 
  n = 59 
Willing to be vaccinated
in the future
Refused 
vaccine 
n = 67 
Willing to be vaccinated
in the future
Figure 1 Willingness to be vaccinated in the future among
National Guard employees serving in the Hajj who either
declined or accepted the H1N1 vaccine (n = 126).
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accepted the vaccine than HCWs. This was consistent
with our previously published finding that physicians
had a low acceptance rate for both seasonal and pan-
demic vaccinations in early 2009/2010 [12].
Despite strong recommendations to vaccinate health-
care workers with the influenza vaccine, coverage was
exceedingly low for all specialties, with some differences
according to location and type of employment [13]. In
addition to education about preventive measures, such as
frequent hand washing and wearing a mask, vaccination
is an essential protective measure. Influenza vaccination
among healthy working adults has been shown to be
highly effective, resulting in a 25% reduction of upper
respiratory illness [14]. In this study, the reasons for refu-
sal included worries about vaccination safety and doubts
about vaccine efficacy. In a study from Hong Kong, the
influenza vaccine was efficient in preventing H1N1 infec-
tion in 61% of the participants [15]. In addition, some
participants believed that other preventive measures
could be applied to yield the same benefits; misleading
information from the media may have been the source of
this reasoning. One of the prominent sources of concern
was the difference in chemical constituents between the
vaccine used in developed countries and those used in
developing countries including the Kingdom. Partici-
pants’ hesitance, worry, and safety concerns about using
a newly developed vaccine were other major determi-
nants of negative response and vaccination refusal. The
most common reasons for accepting the vaccination
were a “wish to be protected” and “following health
authority advice.” The most common reason for refusal
was “w o r r ya b o u ts i d ee f f e c t s . ” In addition, some other
reasons for refusing vaccination included “doubts about
the efficacy of the vaccine,” feeling that it was “not
yet the right time to be vaccinated,” and “simply not
wanting the vaccine [15].” Vaccine-seeking consumers
must first be convinced of a reasonable likelihood that
the disease will occur in their location and that they are
susceptible. Additionally, they must be convinced that
the disease is serious. Finally, they must be convinced of
the safety, if not the efficacy, of the vaccine before they
will accept it [15]. In a recent study conducted on a
group of Saudi civilians, we were able to confirm that the
media played a major role in decreasing the acceptance
of the vaccine. Furthermore, the lack of public education
by knowledgeable HCWs may have also contributed to
popular belief in the negative propaganda [16]. Cam-
paigns and health education in advance to the next
anticipated influenza outbreaks could play an essential
role in encouraging communities to accept vaccinations
during similar future circumstances.
Side effects experienced by the vaccinated individuals
in the cohort consisted of normal short-term adverse
effects [17]. Therefore, the vaccine is promising for
future use if any outbreak is expected, assuming that
further assessment of the long-term adverse effects
yields positive results.
Based on surveillance following the 1976 swine flu
vaccination program, the risk of anaphylaxis from the
influenza vaccination was estimated to be approximately
one in every four million people. In 1976, Guillain-Barré
syndrome was associated with receipt of the swine flu
vaccine, with a risk of 1 per 100,000 individuals vacci-
nated [18]. Safety and efficacy are critical factors in
determining the rate of vaccination in the general popu-
lation. Governments that want to promote H1N1 vacci-
nation will need to gain a better understanding of the
barriers to and facilitators of acceptability before imple-
menting full-scale vaccination programs [19].
The current study demonstrated a substantial
increase in participant awareness. Most participants
understood that applying as many protective measures
as possible allows for the best protection from swine
flu infection. Our results also suggest that frequent
h a n dw a s h i n gi ss e e na so n eo ft h em o s ti n f l u e n t i a l
protective measure. When participants were asked
about future vaccines three weeks after the vaccination
campaign, an increased number of participants (11 out
of 67) had changed their minds and would accept vac-
cination in the future. This change of opinion among
the participants could contribute to a higher accep-
tance rate if vaccinations are offered during future
pandemics. The presence of participants in the same
campus for three weeks post-vaccination, coupled with
an exchange of information between the accepting and
refusing groups, may have been the reasons that some
participants changed their willingness to receive a
future vaccination. HCWs were seriously deficient in
terms of their knowledge of influenza prevention.
Extensive and sustained efforts to overcome these lim-
itations are urgently needed among HCWs, regardless
of whether they are involved in direct or indirect
patient care [20]. These efforts will help to increase
effective compliance among HCWs and the general
public.
Limitations
Several limitations of this study were considered and
acknowledged by our research team. First, the inclusion
of a specific cohort of National Guard employees limits
the wider generalizability and application of the research
findings, as these employees are mainly from the local
area and have extensive experience with the Hajj. There-
fore, our cohort may not feel threatened by participation
in such an international mass gathering. Second, the
small sample size of participants may have hindered the
ability to detect statistical significance; this may have
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sufficiently large to confirm a difference between the
groups).
Conclusions
In the context of global panic surrounding H1N1 and
the possibility of an outbreak in a large gathering such
as the Hajj, this study found that the acceptance rate for
mass vaccination was low among HCWs but acceptable
among non-HCWs. Further, our study recognized and
characterized major barriers preventing H1N1 vaccina-
tion acceptance. Another significant finding of our ana-
lysis was the report of mild (within the normal range)
short-term adverse effects experienced by our cohort.
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